A carregar...

Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data

INTRODUCTION: We present the results of real-life tests conducted in adults affected by psoriatic arthritis (PsA) with mild cutaneous involvement to evaluate the efficacy of certolizumab pegol (CZP), an anti-tumor necrosis factor-alpha agent approved in Europe for the treatment of rheumatoid arthrit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dermatol Ther (Heidelb)
Main Authors: Dattola, Annunziata, Cannizzaro, Maria Vittoria, Mazzeo, Mauro, Bianchi, Luca
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698207/
https://ncbi.nlm.nih.gov/pubmed/29139035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0208-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!